AzTrials
AzTrials

LearningCOraILNCT06178276

Investigation of Neurophysiological Functioning During Oral Comprehension Task

An observational study of Learning and Language, run by University Hospital, Grenoble at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The oral comprehension (OC) of a second language (L2) involves different cognitive processes, specially during the learning phase. This study aims at investigating the neurophysiological functioning of different steps involved in this oral understanding. Read more about this study

Who is it for?
Ages 18 to 35 yearsHealthy volunteers can take part
Conditions the study is for
Learning, Language, Comprehension
What is being tested?
behavior, physiology and imaging
Type of treatment
Pill or oral medicine
How many people
70 participants
Where
1 siteFrance
Study dates
14 Feb 2024to Feb 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 35 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: French learner in Italian language recruited at university

Who may be able to join

  • French learner in Italian language
  • right-handed
  • affiliated to French social security
  • informed consent signed

Who cannot join

  • pregnant woman
  • audiologic pathology impacting the capacity of hearing
  • neurologic or psychiatric pathology that may interfere with oral comprehension
  • learning disability (for instance: dyslexia)
  • contra-indication to MRI and to EDA acquisition

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • University Hospital Grenoble

    Grenoble, 38700

    Chantal M Delon-Martin, PhD, +33 4 56 52 05 89, chantal.delon@univ-grenoble-alpes.fr

    Monica Masperi, PhD, +33 4 76 82 77 48, monica.masperi@univ-grenoble-alpes.fr

    Recruiting

Other trials in France

About this study

Official title: Investigation of Neurophysiological Functioning During Oral Comprehension Task. An Exploratory Study in Second Language (Italian) Learning in French Students Using Autonomic and Cerebral Investigation

The oral comprehension (OC) of a second language (L2) involves different cognitive processes, specially during the learning phase. This study aims at investigating the neurophysiological functioning of different steps involved in this oral understanding.

Read the detailed description

Here, the investigators seek for the different neurophysiological processes involved in OC according to the level of understanding (2 levels) and its different phases (fluid, hindered and metacognitive feedback).

This study therefore requires three different research methodologies :

  1. an interactive system dedicated to the boundary delimitations of obstacles during OC
  2. an investigation of the autonomic nervous system responses (measurement of electrodermal activity and heart rate variability) that will likely occur differently during different phases of the OC process
  3. an investigation of the central responses (through fMRI technique), coupled with autonomous responses, that will identify the different neural networks in the different stages of the OC process.
Being tested
behavior, physiology, imaging
Keywords
Language Learning, Oral comprehension, autonomic activity, brain activity
Medical subject headings
Language

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • behaviorDiagnostic test

    behavioral measurements will be performed during the oral comprehension testing

  • physiologyDiagnostic test

    Also called autonomic

    physiologic (autonomic) measurements will be performed during the oral comprehension testing

  • imagingDiagnostic test

    Also called fMRI

    central (brain) measurements will be performed during the oral comprehension testing

Study groups in NCT06178276
Study groupRoleWhat they receive
A2 levelLevel of oral comprehension in italian language
Receives: Diagnostic Test: behavior; Diagnostic Test: physiology; Diagnostic Test: imaging
B2 levelLevel of oral comprehension in italian language
Receives: Diagnostic Test: behavior; Diagnostic Test: physiology; Diagnostic Test: imaging

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sympathetic activity

    ElectroDermal Activity (EDA) measured in µS

    Measured: up to 3 months following the language profile completion

Secondary outcomes (8)
  1. Parasympathetic activity

    Heart Rate Variability (HRV) measured using the relative power of the high-frequency (HF) component of the HRV (in % of the total power)

    Measured: up to 3 months following the language profile completion

  2. Activated brain regions demonstrating brain activity

    fMRI brain imaging data will be analyzed using Statistical Parametric Mapping (SPM12).

    Measured: up to 6 months following the language profile completion

  3. Correlations between sympathetic and parasympathetic activity

    correlation between EDA components measured in µS and relative power of the HF-HRV

    Measured: up to 3 months following the language profile completion

  4. Interaction between sympathetic activity and brain activity

    Correlation of EDA (µS) with fMRI brain imaging data

    Measured: up to 6 months following the acquisition of language profile

  5. Interaction between parasympathetic activity and brain activity

    Correlation of relative HF component of HRV with the fMRI brain imaging data

    Measured: up to 6 months following the acquisition of language profile

  6. Linguistic evaluation

    Linguistic processes are assessed by performance score on the following tests:

    verbal fluency test in first language (number of items found in 1 min)

    verbal fluency test in second language (number of items found in 1 min)

    Measured: up to 1 month following the acquisition of language profile

  7. Cognitive evaluation of executive functions

    Cognitive evaluation assessed by the following tests:

    Trail Making Test (TMT-A and TMT-B) scores. Time duration (in seconds) for each subtest. Shortest duration meaning efficient executive functions

    Measured: up to 1 month following the acquisition of language profile

  8. Cognitive evaluation of short term memory

    WAIS4 subtest (measured by scores)

    Measured: up to 1 month following the acquisition of language profile

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Dec 2023
  2. Study start14 Feb 2024
  3. Primary completionFeb 2026 (estimated)
  4. Study completionFeb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
70 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06178276
Sponsor's protocol ID
38RC23.0309
Other IDs
2023-A01939-36
Acronym
COraIL
Status last verified
Feb 2024
First submitted
16 Nov 2023
Last updated
16 Feb 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: anonymised, processed data will be shared after publication acceptance on dedicated sites

Questions about this trial

What is this clinical trial studying?

An observational study of Learning and Language, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Chantal M Delon-Martin, PhD (+33 4 56 52 05 89, chantal.delon@univ-grenoble-alpes.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sympathetic activity (time frame: up to 3 months following the language profile completion). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2024; AzTrials last refreshed its copy on 1 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in